Literature DB >> 25033948

[Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE].

B Lehmann1, B Heimes, M Gutfleisch, G Spital, D Pauleikhoff, A Lommatzsch.   

Abstract

PURPOSE: Are there any morphological parameters in pigment epithelial detachment (PED) in eyes with age-related macular degeneration (AMD), which could identify the development of tears (RIP) in the retinal pigment epithelium (RPE) before initiation of anti-vascular endothelial growth factor (VEGF) therapy?
METHODS: Retrospectively, the spectral domain optical coherence tomography (SD-OCT), FLA and near infrared (NIR) images of 98 eyes with PED in exudative AMD before treatment (ranibizumab or bevacizumab) were analyzed. Eyes in which a tear in the RPE (RIP group) could be observed during treatment were compared to eyes without the development of RIP (PED group) in the following morphological parameters of PED: height, number of peaks, presence of hyporeflective fissures at the base of the PED, structure of the RPE, presence of floating structures in the PED with maximum hyperreflectivity, amount and localization of hyperreflectivity in the PED and hyperreflectivity in the NIR images.
RESULTS: In the 80 eyes of the PED group the mean PED height was 373.7± 197 µm and in the 18 eyes of the RIP group the mean PED height was higher (694.2± 284.3 µm, p < 0.0001). A difference was also seen in the number of peaks per PED (PED group 43%, RIP group 72%, p = 0.039) and in the hyperreflectivity in NIR images (PED group 68%, RIP group 94%, p = 0.033). There were no significant differences in the other morphological parameters. A classification into four types of PED was found by the parameters height and number of peaks. The PED type with a height > 350 µm and one peak (RIP 43%) developed tears more often (p = 0.001) than the PED type < 350 µm with one peak (RIP 0%, p = 0.001). A trend in the visual acuity over 156 weeks was seen: in PED types with heights > 350 µm there was a lower increase in the visual acuity than in PED types < 350 µm (rm ANOVA p = 0.18; ɛ HH = 0.88). Furthermore, in PED types > 350 µm with multiple peaks the total number of injections necessary was higher than in the other PED types (p = 0.032).
CONCLUSION: Morphological parameters, such as PED height, number of peaks per PED in OCT images and hyperreflectivity in NIR images are prognostic factors for RPE tears in exudative AMD. The PED height and number of peaks per PED are useful for classification of PED in the daily routine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25033948     DOI: 10.1007/s00347-014-3098-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  34 in total

1.  Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear.

Authors:  B A Lafaut; S Aisenbrey; C Vanden Broecke; R Krott; C P Jonescu-Cuypers; S Reynders; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications.

Authors:  D Pauleikhoff; D Löffert; G Spital; M Radermacher; J Dohrmann; A Lommatzsch; A C Bird
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-06-25       Impact factor: 3.117

3.  Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration.

Authors:  Florence Coscas; Gabriel Coscas; Eric Souied; Sarah Tick; Gisele Soubrane
Journal:  Am J Ophthalmol       Date:  2007-08-15       Impact factor: 5.258

4.  Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.

Authors:  Clement K Chan; Prema Abraham; Carsten H Meyer; Gregg T Kokame; Peter K Kaiser; Michael E Rauser; Jeffrey G Gross; Asha S D Nuthi; Steven G Lin; Noha S Daher
Journal:  Retina       Date:  2010-02       Impact factor: 4.256

5.  Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy.

Authors:  David Sarraf; Clement Chan; Ehsan Rahimy; Prema Abraham
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

Review 6.  Retinal pigment epithelial detachments in the elderly.

Authors:  A C Bird; J Marshall
Journal:  Trans Ophthalmol Soc U K       Date:  1986

7.  [Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].

Authors:  A Lommatzsch; B Heimes; M Gutfleisch; G Spital; M Dietzel; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

8.  [Tear in retinal pigment epithelium under anti-VEGF therapy for exudative age-related macular degeneration : function recovery under intensive therapy].

Authors:  S Bartels; A Barrelmann; B Book; B Heimes; M Gutfleisch; G Spital; D Pauleikhoff; A Lommatzsch
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

Review 9.  Tears of the retinal pigment epithelium: an old problem in a new era.

Authors:  Louis K Chang; David Sarraf
Journal:  Retina       Date:  2007-06       Impact factor: 4.256

10.  Effect of intravitreal ranibizumab in avascular pigment epithelial detachment.

Authors:  M Ritter; M Bolz; S Sacu; G G Deák; C Kiss; C Pruente; U M Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2009-11-13       Impact factor: 3.775

View more
  4 in total

1.  [OCT angiography for exudative age-related macular degeneration : Initial experiences].

Authors:  A Lommatzsch; M-L Farecki; B Book; B Heimes; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

2.  [Forms of age-related macular degeneration].

Authors:  M Schargus
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

3.  The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.

Authors:  F Treumer; S Wienand; K Purtskhvanidze; J Roider; J Hillenkamp
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-09       Impact factor: 3.117

4.  Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid.

Authors:  Alper Bilgic; Laurent Kodjikian; Shail Vasavada; Shyamal Jha; Samaresh Srivastava; Aditya Sudhalkar; Thibaud Mathis
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.